跳至主要内容
临床试验/NCT00813358
NCT00813358已完成不适用

Zenith TX2® TAA Endovascular Graft Post-approval Study

Cook Research Incorporated49 个研究点 分布在 2 个国家目标入组 115 人开始时间: 2009年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
115
试验地点
49
主要终点
Number of Participants With Freedom From Thoracic Aortic Aneurysm-related Mortality

研究概览

简要总结

The Zenith TX2® Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2® TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Descending thoracic aortic aneurysm with diameter greater than or equal to 5.0 cm; or
  • Descending thoracic aortic aneurysm with a history of growth greater than or equal to 0.5 cm within the previous 12 months; or
  • Descending thoracic aortic degenerative or atherosclerotic ulcers greater than or equal to 10 mm in depth and 20 mm in diameter

排除标准

  • Age less than 18 years
  • Other medical condition that may cause the patient to be non-compliant with the protocol, confound the results, or is associated with limited life expectancy (i.e., less than 2 years)
  • Pregnant, breast-feeding, or planning on becoming pregnant within 24 months
  • Unwilling or unable to comply with the follow-up schedule
  • Inability or refusal to give informed consent
  • Simultaneously participating in another investigative device or drug study

结局指标

主要结局

Number of Participants With Freedom From Thoracic Aortic Aneurysm-related Mortality

时间窗: 5 years

Thoracic aortic aneurysm-related mortality defined as death from any cause occurring within 30 days of the initial procedure or a secondary intervention; or any death determined by the independent clinical events committee to be causally related to the initial implant procedure, secondary intervention, or rupture of the treated aneurysm.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (49)

Loading locations...

相似试验

Zenith TX2® Post-market Approval Study | 临床试验